Stockreport

ADMA Biologics: Why The Dip To $16 Resets The Buy Case [Seeking Alpha]

ADMA Biologics Inc  (ADMA) 
Last adma biologics inc earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.admabiologics.com
PDF ADMA's Asceniv drives robust revenue and margin expansion, with 2026 revenue guided at $630M and EBITDA margin at 56%. Yield-enhanced manufacturing and facility expan [Read more]